CREEGH PHARMACEUTICALS INC
Pittsburgh, PA · Founded 2018 · CIK 0001817450 · Biotech · Private
Nitro fatty acid compounds (CP-8) that inhibit RAD51-mediated homologous recombination DNA repair to sensitize triple-negative breast cancer to PARP inhibitors and radiation
- Grants
- $797K
- 2 awards
- Sector median: 1
- Raised
- $500K
- 1 Form D · Jul 2020
- 75 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Synergize a novel homologous recombination inhibitor with DNA damagingagents in TNBC | $398,728 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Synergize a novel homologous recombination inhibitor with DNA damagingagents in TNBC | $398,728 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2230 | Inflection Medicine | — | — |
| 2231 | Tenvie | — | — |
| 2232 | MITO-BIOTHERAPEUTICS, INC. | — | — |
| 2233 | CREEGH PHARMACEUTICALS INC | — | $500K |
| 2234 | Advac Therapeutic LLC | — | — |
| 2235 | I Peace, Inc. | — | $47M |
| 2236 | L.E.A.F. Pharmaceuticals LLC | — | $40M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bruce FreemanDirector · Executive Officer
- Francisco SchopferDirector · Executive Officer
- Joshua TarnoffDirector
- Margaret TarpeyExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.